Understanding glucose distribution in severely burned adults
Official title: INDICIA: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults
Run by Centre Hospitalier Régional Metz-Thionville · NCT06469970 · Data updated 2026-11-12
This study is testing how glucose levels change in severely burned adults during their first four days of treatment to help doctors manage their fluids better and improve recovery.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Centre Hospitalier Régional Metz-Thionville Academic / other |
| Locations | 1 site (Metz) |
| Status | Recruiting |
| Started | November 28, 2024 |
| Main results expected | March 28, 2027 |
| Study ends | March 28, 2027 |
| Registry record updated | March 12, 2026 |
| Trial ID | NCT06469970 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old with burns covering at least 30% of their body surface area, treated within 8 hours post-injury at the specified burn center.
✕Probably not a fit
Patients with diabetes requiring insulin or those with contraindications to glucose administration will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, observational, phase II cohort study aims to explore how the initial volume of glucose distribution changes during the first four days of treatment for severely burned patients. It focuses on the challenges of fluid resuscitation in burn victims, who often experience hypovolaemic shock and capillary leak syndrome. By administering a 30% intravenous glucose solution, the study seeks to quantify extracellular fluid volume as a potential marker for fluid overload, which is critical for optimizing patient management and improving outcomes.
Why it matters
Potential benefit: If successful, this study could enhance fluid management strategies for severely burned patients, potentially reducing complications and mortality.
How similar studies have gone: While the approach of using glucose to assess fluid distribution is innovative, similar studies have not been widely reported, indicating this may be a novel exploration.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age * Patients hospitalized with burns of at least 30% of body surface area * By a thermal mechanism * At the CHR Metz-Thionville burn center * managed within the 8 hours post-burn * Patient affiliated to a social security scheme * Written consent obtained from the patient (or from the trusted person, family or relatives if the patient is unable to sign/express consent) or emergency inclusion if the patient is unable to express consent and neither the trusted support person nor any member of the family or relatives is present at the time of inclusion. Exclusion Criteria: * Diabetic patients on insulin * Patient with a CONTRAINDICATION to GLUCOSE 30% PROAMP, solution for injection * Patients with pre-hospital cardiac arrest * extra corporeal circulation patient: Extra Corporeal Membranous Oxygenation (ECMO) or Extra Corporeal Life Support (ECLS) or CRRT (Continuous Renal Replacement Therapy) * patient without a central venous line or arterial catheter * Patient moribund or immediately subject to therapeutic limitation * Impossibility of trans-pulmonary thermodilution monitoring (vascular access difficulties) * Pregnant, parturient or breast-feeding women * Patient under guardianship, curatorship or safeguard of justice * Cognitive impairment or language barrier
Where it's running
-
CHR Metz-Thionville/Hopital de Mercy
Metz, France Recruiting
Study contacts
- Principal investigator: Serge LE TACON, MD — CHR Metz Thionville Hopital de Mercy
- Study coordinator: Arpiné EL NAR, PhD
- Email: projet-recherche-clinique@chr-metz-thionville.fr
- Phone: 0033387557766
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early detection of sepsis-related blood clotting problems in severe burn patients
This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.
-
Structured education for families of patients with tracheostomy in the ICU
This trial tests whether giving a structured education session to family members of ICU patients with tracheostomies can reduce their state anxiety and improve well-being and satisfaction with care.
-
THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers
This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.
-
Help for uninsured kids: connect to NJ FamilyCare in the ED
This ED-based program tries to see if uninsured children can enroll or re-enroll in NJ FamilyCare by giving families direct help and a quick survey about barriers.
-
Efferon LPS hemoadsorption for severe burns
This study tests whether adding Efferon LPS hemoadsorption to standard care can help burn patients with high illness scores see if their symptoms improve and prevent organ failure.
-
Wearable hip-robot training to improve walking after major lower-leg burns
This 12-week program will try using a wearable hip-assist robot during daily physiotherapy to help adults who still have walking problems six months after large lower-extremity burns walk better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.